43325dkk
0,1 %
Date:2025-05-15Time:12:39:49Latest report:Q1-2025List:Large CapTicker:NOVO B
Market Cap:1 934 461 mdkkEnterprise Value:2 012 470 mdkkNet Sales:303 141 mdkkEarnings:104 615 mdkkEmployees:0ISIN:DK0062498333

Ratios

10-year key figure history for Novo Nordisk turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Novo Nordisk with index and moving average MA50 and MA200.

Stockprice:433,25
MA50:474,89
MA200:684,48
Price/MA200:-36,7 %
RSI (14):45,6
Price/MA50:-8,8 %

Description

Novo Nordisk is a producer of insulin for diabetes treatment. In addition to the specialist expertise in diabetes, the company produces drugs for hormone treatment as well as for hemophilia and bleeding disorders. The products are found on a global market and are sold under separate brands. Novo Nordisk was founded in 1923 and is headquartered in Bagsværd, Denmark.

Pharmaceuticals